Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for VCEL

Stock Name	Vericel Corp Ord
Ticker	VCEL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US92346J1088
LEI	54930076YM3PLTDR4B91

Show aggregate VCEL holdings

News associated with VCEL

BTIG Research Downgrades Vericel (NASDAQ:VCEL) to Neutral: Vericel (NASDAQ:VCEL – Get Free Report) was downgraded by BTIG Research from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, MarketBeat.com reports. VCEL has been the subject of a number of other research reports. Stephens reiterated an “overweight” rating and issued a $67.00 price objective on shares of […] - 2025-09-19 02:50:54
Vericel (NASDAQ:VCEL) Shares Gap Down Following Analyst Downgrade: Vericel Corporation (NASDAQ:VCEL – Get Free Report)’s share price gapped down prior to trading on Wednesday after BTIG Research downgraded the stock from a buy rating to a neutral rating. The stock had previously closed at $33.23, but opened at $31.85. Vericel shares last traded at $31.15, with a volume of 120,872 shares. A number […] - 2025-09-19 02:18:56
Vericel (NASDAQ:VCEL) Reaches New 52-Week Low on Analyst Downgrade: Vericel Corporation (NASDAQ:VCEL – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after BTIG Research downgraded the stock from a buy rating to a neutral rating. The company traded as low as $29.93 and last traded at $30.02, with a volume of 1683483 shares traded. The stock had previously closed […] - 2025-09-18 03:06:42
Vericel Corporation (NASDAQ:VCEL) Given Average Recommendation of “Buy” by Brokerages: Vericel Corporation (NASDAQ:VCEL – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have covered the stock in the last year […] - 2025-08-21 04:24:45
Maryland State Retirement & Pension System Cuts Holdings in Vericel Corporation (NASDAQ:VCEL): Maryland State Retirement & Pension System trimmed its holdings in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 13.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 14,387 shares of the biotechnology company’s stock after selling 2,170 shares during the […] - 2025-08-14 05:17:00
Vericel Corporation (NASDAQ:VCEL) Shares Bought by Mutual of America Capital Management LLC: Mutual of America Capital Management LLC grew its stake in Vericel Corporation (NASDAQ:VCEL – Free Report) by 5.9% during the 1st quarter, Holdings Channel reports. The fund owned 158,930 shares of the biotechnology company’s stock after acquiring an additional 8,789 shares during the period. Mutual of America Capital Management LLC’s holdings in Vericel were worth […] - 2025-08-08 04:30:54
Geneva Capital Management LLC Has $60.94 Million Stock Holdings in Vericel Corporation (NASDAQ:VCEL): Geneva Capital Management LLC grew its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 24.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,365,744 shares of the biotechnology company’s stock after purchasing an additional 265,956 shares during the quarter. Vericel […] - 2025-08-04 04:28:58
Envestnet Asset Management Inc. Raises Stock Position in Vericel Corporation (NASDAQ:VCEL): Envestnet Asset Management Inc. lifted its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 15.6% during the first quarter, Holdings Channel reports. The institutional investor owned 204,510 shares of the biotechnology company’s stock after buying an additional 27,526 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Vericel were worth $9,125,000 as of […] - 2025-07-22 06:48:58
Principal Financial Group Inc. Grows Stake in Vericel Corporation (NASDAQ:VCEL): Principal Financial Group Inc. lifted its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.7% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 270,154 shares of the biotechnology company’s stock after purchasing an additional 7,222 shares during the period. Principal Financial Group Inc.’s holdings in Vericel were worth $12,054,000 as of its […] - 2025-07-14 04:52:59
Vericel Corporation (NASDAQ:VCEL) Shares Sold by Amalgamated Bank: Amalgamated Bank trimmed its holdings in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,010 shares of the biotechnology company’s stock after selling 375 shares during the quarter. Amalgamated […] - 2025-07-10 04:40:59
Oregon Public Employees Retirement Fund Cuts Holdings in Vericel Corporation (NASDAQ:VCEL): Oregon Public Employees Retirement Fund decreased its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.6% in the first quarter, Holdings Channel reports. The institutional investor owned 11,293 shares of the biotechnology company’s stock after selling 300 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Vericel were worth $504,000 as of […] - 2025-07-08 05:24:54
Allspring Global Investments Holdings LLC Reduces Holdings in Vericel Corporation (NASDAQ:VCEL): Allspring Global Investments Holdings LLC trimmed its position in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 4.5% in the 1st quarter, Holdings Channel reports. The institutional investor owned 249,441 shares of the biotechnology company’s stock after selling 11,632 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Vericel were worth $10,747,000 […] - 2025-07-04 04:52:25
Vericel Corporation (NASDAQ:VCEL) Given Average Rating of “Buy” by Brokerages: Shares of Vericel Corporation (NASDAQ:VCEL – Get Free Report) have been assigned an average recommendation of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have updated their coverage on […] - 2025-07-02 05:08:59
Vericel (NASDAQ:VCEL) Receives Overweight Rating from Stephens: Vericel (NASDAQ:VCEL – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Stephens in a research note issued on Monday,Benzinga reports. They presently have a $67.00 price objective on the biotechnology company’s stock. Stephens’ price objective would suggest a potential upside of 61.45% from the company’s previous close. A number of […] - 2025-06-18 03:02:52
GAMMA Investing LLC Has $5.76 Million Position in Vericel Co. (NASDAQ:VCEL): GAMMA Investing LLC raised its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 5,916.5% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 129,175 shares of the biotechnology company’s stock after purchasing an additional 127,028 shares during the quarter. GAMMA Investing LLC’s holdings in Vericel were worth $5,764,000 at the […] - 2025-06-10 04:38:49
Brokerages Set Vericel Co. (NASDAQ:VCEL) Target Price at $61.14: Vericel Co. (NASDAQ:VCEL – Get Free Report) has been assigned a consensus rating of “Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have covered the stock in the last year […] - 2025-06-10 03:14:49
Mackenzie Financial Corp Acquires New Stake in Vericel Co. (NASDAQ:VCEL): Mackenzie Financial Corp bought a new position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 3,924 shares of the biotechnology company’s stock, valued at approximately $215,000. A number of other hedge funds and other institutional investors also recently bought and sold shares of VCEL. […] - 2025-06-06 04:50:53
Vericel Co. (NASDAQ:VCEL) Shares Acquired by Deutsche Bank AG: Deutsche Bank AG grew its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 32.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 52,999 shares of the biotechnology company’s stock after buying an additional 12,890 shares during the quarter. Deutsche Bank AG’s holdings in Vericel were worth $2,910,000 as of its most recent SEC […] - 2025-05-22 04:45:02
BNP Paribas Financial Markets Reduces Stake in Vericel Co. (NASDAQ:VCEL): BNP Paribas Financial Markets lowered its position in Vericel Co. (NASDAQ:VCEL – Free Report) by 35.1% in the 4th quarter, Holdings Channel reports. The fund owned 20,699 shares of the biotechnology company’s stock after selling 11,202 shares during the quarter. BNP Paribas Financial Markets’ holdings in Vericel were worth $1,137,000 as of its most recent […] - 2025-05-21 04:30:48
Vericel (NASDAQ:VCEL) Rating Lowered to “Sell” at StockNews.com: Vericel (NASDAQ:VCEL – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Monday. VCEL has been the topic of a number of other research reports. Stephens reaffirmed an “overweight” rating and set a $65.00 target price on shares of Vericel […] - 2025-05-14 02:14:47
The Manufacturers Life Insurance Company Sells 526 Shares of Vericel Co. (NASDAQ:VCEL): The Manufacturers Life Insurance Company lowered its position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 2.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,593 shares of the biotechnology company’s stock after selling 526 shares during […] - 2025-05-13 05:22:54
Price T Rowe Associates Inc. MD Decreases Stake in Vericel Co. (NASDAQ:VCEL): Price T Rowe Associates Inc. MD lowered its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 2.9% during the fourth quarter, HoldingsChannel reports. The fund owned 29,479 shares of the biotechnology company’s stock after selling 868 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Vericel were worth $1,619,000 as of […] - 2025-05-09 05:47:10
Vericel Co. (NASDAQ:VCEL) Stock Position Boosted by Mariner LLC: Mariner LLC grew its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 7.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 9,209 shares of the biotechnology company’s stock after acquiring an additional 659 shares during the period. Mariner LLC’s holdings in Vericel were worth $506,000 at the end of […] - 2025-05-02 05:09:04
Renaissance Technologies LLC Buys 9,200 Shares of Vericel Co. (NASDAQ:VCEL): Renaissance Technologies LLC increased its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 11.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 89,500 shares of the biotechnology company’s stock after purchasing an additional 9,200 shares during the period. Renaissance Technologies LLC’s […] - 2025-04-21 04:46:48
Brokerages Set Vericel Co. (NASDAQ:VCEL) Target Price at $60.86: Vericel Co. (NASDAQ:VCEL – Get Free Report) has received a consensus recommendation of “Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have covered the stock in the last year is […] - 2025-04-21 02:30:46
Alliancebernstein L.P. Reduces Stake in Vericel Co. (NASDAQ:VCEL): Alliancebernstein L.P. reduced its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 5.5% in the fourth quarter, Holdings Channel reports. The fund owned 54,730 shares of the biotechnology company’s stock after selling 3,160 shares during the quarter. Alliancebernstein L.P.’s holdings in Vericel were worth $3,005,000 as of its most recent filing with […] - 2025-04-16 04:31:00
Vericel Co. (NASDAQ:VCEL) Shares Sold by Sei Investments Co.: Sei Investments Co. cut its stake in Vericel Co. (NASDAQ:VCEL – Free Report) by 8.2% in the fourth quarter, Holdings Channel reports. The firm owned 59,945 shares of the biotechnology company’s stock after selling 5,320 shares during the period. Sei Investments Co.’s holdings in Vericel were worth $3,291,000 as of its most recent filing with […] - 2025-04-04 06:28:59
Vericel Co. (NASDAQ:VCEL) Stake Reduced by Corebridge Financial Inc.: Corebridge Financial Inc. trimmed its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 6.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 26,155 shares of the biotechnology company’s stock after selling 1,682 shares during the quarter. Corebridge Financial Inc.’s holdings in Vericel […] - 2025-04-04 05:41:01
Prudential Financial Inc. Sells 4,199 Shares of Vericel Co. (NASDAQ:VCEL): Prudential Financial Inc. decreased its holdings in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 7.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,004 shares of the biotechnology company’s stock after selling 4,199 shares during the period. […] - 2025-04-04 04:31:04
Avantax Advisory Services Inc. Purchases 234 Shares of Vericel Co. (NASDAQ:VCEL): Avantax Advisory Services Inc. boosted its position in Vericel Co. (NASDAQ:VCEL – Free Report) by 1.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,803 shares of the biotechnology company’s stock after acquiring an additional 234 shares during the period. Avantax […] - 2025-03-21 06:47:07

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc VCEL holdings

Date	Number of VCEL Shares Held	Base Market Value of VCEL Shares	Local Market Value of VCEL Shares	Change in VCEL Shares Held	Change in VCEL Base Value	Current Price per VCEL Share Held	Previous Price per VCEL Share Held
2026-01-15 (Thursday)	4,747	USD 183,092	USD 183,092	728	USD 33,063	USD 38.57	USD 37.3299
2026-01-14 (Wednesday)	4,019	USD 150,029	USD 150,029	14	USD 1,644	USD 37.3299	USD 37.0499
2026-01-13 (Tuesday)	4,005	USD 148,385	USD 148,385	0	USD 1,842	USD 37.0499	USD 36.59
2026-01-12 (Monday)	4,005	USD 146,543	USD 146,543	0	USD -7,890	USD 36.59	USD 38.5601
2026-01-09 (Friday)	4,005	USD 154,433	USD 154,433	0	USD -8,691	USD 38.5601	USD 40.7301
2026-01-08 (Thursday)	4,005	USD 163,124	USD 163,124	14	USD 2,087	USD 40.7301	USD 40.35
2026-01-07 (Wednesday)	3,991	USD 161,037	USD 161,037	0	USD 4,031	USD 40.35	USD 39.34
2026-01-06 (Tuesday)	3,991	USD 157,006	USD 157,006	0	USD 9,020	USD 39.34	USD 37.0799
2026-01-05 (Monday)	3,991	USD 147,986	USD 147,986	0	USD 5,866	USD 37.0799	USD 35.6101
2026-01-02 (Friday)	3,991	USD 142,120	USD 142,120	0	USD -1,596	USD 35.6101	USD 36.01
2025-12-31 (Wednesday)	3,991	USD 143,716	USD 143,716	0	USD -2,873	USD 36.01	USD 36.7299

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VCEL by Blackrock for IE00B3VWM098

Show aggregate share trades of VCEL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-01-15 BUY 728 38.570* 43.71
2026-01-14 BUY 14 37.330* 43.74
2026-01-08 BUY 14 40.730* 43.83
2025-12-23 SELL -14 37.620 36.740 36.828 USD -516 44.11 Profit of 102 on sale
2025-12-03 SELL -70 38.190 37.350 37.434 USD -2,620 44.59 Profit of 501 on sale
2025-12-02 BUY 28 39.140 37.320 37.502 USD 1,050 44.62
2025-11-25 SELL -42 42.640 39.290 39.625 USD -1,664 44.72 Profit of 214 on sale
2025-11-24 SELL -42 40.130 38.330 38.510 USD -1,617 44.75 Profit of 262 on sale
2025-11-17 SELL -154 40.390 39.240 39.355 USD -6,061 44.90 Profit of 853 on sale
2025-11-12 SELL -14 41.660 40.370 40.499 USD -567 44.97 Profit of 63 on sale
2025-11-06 SELL -14 43.000 38.740 39.166 USD -548 45.08 Profit of 83 on sale
2025-11-05 SELL -140 37.260 35.440 35.622 USD -4,987 45.12 Profit of 1,330 on sale
2025-11-04 SELL -28 36.710 35.620 35.729 USD -1,000 45.17 Profit of 264 on sale
2025-11-03 SELL -28 37.000 34.380 34.642 USD -970 45.22 Profit of 296 on sale
2025-10-28 BUY 42 36.830 36.860 36.857 USD 1,548 45.43
2025-10-24 SELL -14 36.320 36.480 36.464 USD -510 45.53 Profit of 127 on sale
2025-10-15 BUY 84 33.590 35.050 34.904 USD 2,932 45.92
2025-10-02 BUY 14 31.520 31.580 31.574 USD 442 46.08
2025-09-30 BUY 28 31.470 31.980 31.929 USD 894 46.25
2025-08-21 SELL -14 35.440 35.790 35.755 USD -501 46.69 Profit of 153 on sale
2025-07-31 BUY 42 34.940 38.270 37.937 USD 1,593 46.83
2025-06-30 SELL -28 42.550 43.570 43.468 USD -1,217 47.78 Profit of 121 on sale
2025-06-25 SELL -14 41.880 43.460 43.302 USD -606 47.90 Profit of 64 on sale
2025-06-20 SELL -28 42.020 42.750 42.677 USD -1,195 48.02 Profit of 150 on sale
2025-05-23 BUY 14 40.920 41.310 41.271 USD 578 48.96
2025-05-19 SELL -14 42.540 43.250 43.179 USD -605 49.20 Profit of 84 on sale
2025-05-15 SELL -42 41.490 42.550 42.444 USD -1,783 49.32 Profit of 289 on sale
2025-05-12 SELL -14 42.650 44.270 44.108 USD -618 49.50 Profit of 75 on sale
2025-05-09 SELL -14 41.730 43.000 42.873 USD -600 49.57 Profit of 94 on sale
2025-04-30 SELL -14 38.020 38.980 38.884 USD -544 50.26 Profit of 159 on sale
2025-04-24 SELL -28 41.090 41.150 41.144 USD -1,152 50.68 Profit of 267 on sale
2025-04-17 SELL -14 41.230 41.590 41.554 USD -582 51.21 Profit of 135 on sale
2025-04-15 SELL -42 42.020 42.370 42.335 USD -1,778 51.42 Profit of 382 on sale
2025-04-14 SELL -42 41.230 42.560 42.427 USD -1,782 51.53 Profit of 383 on sale
2025-04-09 SELL -56 44.240 44.600 44.564 USD -2,496 51.84 Profit of 407 on sale
2025-04-07 SELL -98 39.900 42.580 42.312 USD -4,147 52.13 Profit of 962 on sale
2025-04-04 SELL -140 41.920 43.120 43.000 USD -6,020 52.25 Profit of 1,295 on sale
2025-03-31 BUY 14 44.620 44.700 44.692 USD 626 52.55
2025-03-19 SELL -28 47.430 47.550 47.538 USD -1,331 53.17 Profit of 158 on sale
2025-03-14 SELL -84 45.380 47.160 46.982 USD -3,946 53.45 Profit of 543 on sale
2025-03-13 SELL -28 45.390 46.360 46.263 USD -1,295 53.56 Profit of 204 on sale
2025-03-12 SELL -476 45.810 48.510 48.240 USD -22,962 53.67 Profit of 2,586 on sale
2025-03-07 SELL -28 49.560 50.360 50.280 USD -1,408 53.89 Profit of 101 on sale
2025-03-06 SELL -42 48.760 51.450 51.181 USD -2,150 53.97 Profit of 117 on sale
2025-03-03 SELL -14 49.510 52.000 51.751 USD -725 54.13 Profit of 33 on sale
2025-02-28 SELL -84 51.290 51.670 51.632 USD -4,337 54.17 Profit of 213 on sale
2025-02-26 SELL -14 52.850 53.560 53.489 USD -749 54.27 Profit of 11 on sale
2025-02-25 SELL -42 52.520 52.700 52.682 USD -2,213 54.30 Profit of 68 on sale
2025-02-18 BUY 70 57.280 58.770 58.621 USD 4,103 54.19
2025-02-13 BUY 14 56.810 57.260 57.215 USD 801 54.02
2025-02-12 BUY 14 56.020 56.720 56.650 USD 793 53.98
2025-02-11 BUY 42 57.510 58.470 58.374 USD 2,452 53.91
2025-02-06 BUY 126 59.700 62.150 61.905 USD 7,800 53.58
2025-01-27 BUY 14 59.720 59.840 59.828 USD 838 52.27
2024-12-30 BUY 70 55.300 56.970 56.803 USD 3,976 51.78
2024-12-06 BUY 56 56.370 57.180 57.099 USD 3,198 51.28
2024-12-05 BUY 14 56.520 58.560 58.356 USD 817 51.10
2024-12-04 BUY 70 58.150 59.850 59.680 USD 4,178 50.85
2024-11-29 BUY 70 58.140 58.500 58.464 USD 4,092 49.95
2024-11-27 BUY 56 57.760 59.830 59.623 USD 3,339 49.27
2024-11-26 BUY 14 58.750 58.810 58.804 USD 823 48.84
2024-11-21 BUY 70 56.710 58.490 58.312 USD 4,082 47.37
2024-11-20 BUY 42 57.260 57.340 57.332 USD 2,408 46.82
2024-11-18 BUY 168 52.890 53.780 53.691 USD 9,020 45.88
2024-11-12 BUY 112 55.890 57.810 57.618 USD 6,453 45.21
2024-11-08 BUY 70 54.000 54.470 54.423 USD 3,810 44.58
2024-11-07 BUY 210 50.030 50.760 50.687 USD 10,644 44.16
2024-11-06 BUY 28 48.040 48.770 48.697 USD 1,364 43.84
2024-10-31 BUY 14 44.040 45.610 45.453 USD 636 43.62
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-01-15	BUY	728			38.570*		43.71
2026-01-14	BUY	14			37.330*		43.74
2026-01-08	BUY	14			40.730*		43.83
2025-12-23	SELL	-14	37.620	36.740	36.828	USD -516	44.11 Profit of 102 on sale
2025-12-03	SELL	-70	38.190	37.350	37.434	USD -2,620	44.59 Profit of 501 on sale
2025-12-02	BUY	28	39.140	37.320	37.502	USD 1,050	44.62
2025-11-25	SELL	-42	42.640	39.290	39.625	USD -1,664	44.72 Profit of 214 on sale
2025-11-24	SELL	-42	40.130	38.330	38.510	USD -1,617	44.75 Profit of 262 on sale
2025-11-17	SELL	-154	40.390	39.240	39.355	USD -6,061	44.90 Profit of 853 on sale
2025-11-12	SELL	-14	41.660	40.370	40.499	USD -567	44.97 Profit of 63 on sale
2025-11-06	SELL	-14	43.000	38.740	39.166	USD -548	45.08 Profit of 83 on sale
2025-11-05	SELL	-140	37.260	35.440	35.622	USD -4,987	45.12 Profit of 1,330 on sale
2025-11-04	SELL	-28	36.710	35.620	35.729	USD -1,000	45.17 Profit of 264 on sale
2025-11-03	SELL	-28	37.000	34.380	34.642	USD -970	45.22 Profit of 296 on sale
2025-10-28	BUY	42	36.830	36.860	36.857	USD 1,548	45.43
2025-10-24	SELL	-14	36.320	36.480	36.464	USD -510	45.53 Profit of 127 on sale
2025-10-15	BUY	84	33.590	35.050	34.904	USD 2,932	45.92
2025-10-02	BUY	14	31.520	31.580	31.574	USD 442	46.08
2025-09-30	BUY	28	31.470	31.980	31.929	USD 894	46.25
2025-08-21	SELL	-14	35.440	35.790	35.755	USD -501	46.69 Profit of 153 on sale
2025-07-31	BUY	42	34.940	38.270	37.937	USD 1,593	46.83
2025-06-30	SELL	-28	42.550	43.570	43.468	USD -1,217	47.78 Profit of 121 on sale
2025-06-25	SELL	-14	41.880	43.460	43.302	USD -606	47.90 Profit of 64 on sale
2025-06-20	SELL	-28	42.020	42.750	42.677	USD -1,195	48.02 Profit of 150 on sale
2025-05-23	BUY	14	40.920	41.310	41.271	USD 578	48.96
2025-05-19	SELL	-14	42.540	43.250	43.179	USD -605	49.20 Profit of 84 on sale
2025-05-15	SELL	-42	41.490	42.550	42.444	USD -1,783	49.32 Profit of 289 on sale
2025-05-12	SELL	-14	42.650	44.270	44.108	USD -618	49.50 Profit of 75 on sale
2025-05-09	SELL	-14	41.730	43.000	42.873	USD -600	49.57 Profit of 94 on sale
2025-04-30	SELL	-14	38.020	38.980	38.884	USD -544	50.26 Profit of 159 on sale
2025-04-24	SELL	-28	41.090	41.150	41.144	USD -1,152	50.68 Profit of 267 on sale
2025-04-17	SELL	-14	41.230	41.590	41.554	USD -582	51.21 Profit of 135 on sale
2025-04-15	SELL	-42	42.020	42.370	42.335	USD -1,778	51.42 Profit of 382 on sale
2025-04-14	SELL	-42	41.230	42.560	42.427	USD -1,782	51.53 Profit of 383 on sale
2025-04-09	SELL	-56	44.240	44.600	44.564	USD -2,496	51.84 Profit of 407 on sale
2025-04-07	SELL	-98	39.900	42.580	42.312	USD -4,147	52.13 Profit of 962 on sale
2025-04-04	SELL	-140	41.920	43.120	43.000	USD -6,020	52.25 Profit of 1,295 on sale
2025-03-31	BUY	14	44.620	44.700	44.692	USD 626	52.55
2025-03-19	SELL	-28	47.430	47.550	47.538	USD -1,331	53.17 Profit of 158 on sale
2025-03-14	SELL	-84	45.380	47.160	46.982	USD -3,946	53.45 Profit of 543 on sale
2025-03-13	SELL	-28	45.390	46.360	46.263	USD -1,295	53.56 Profit of 204 on sale
2025-03-12	SELL	-476	45.810	48.510	48.240	USD -22,962	53.67 Profit of 2,586 on sale
2025-03-07	SELL	-28	49.560	50.360	50.280	USD -1,408	53.89 Profit of 101 on sale
2025-03-06	SELL	-42	48.760	51.450	51.181	USD -2,150	53.97 Profit of 117 on sale
2025-03-03	SELL	-14	49.510	52.000	51.751	USD -725	54.13 Profit of 33 on sale
2025-02-28	SELL	-84	51.290	51.670	51.632	USD -4,337	54.17 Profit of 213 on sale
2025-02-26	SELL	-14	52.850	53.560	53.489	USD -749	54.27 Profit of 11 on sale
2025-02-25	SELL	-42	52.520	52.700	52.682	USD -2,213	54.30 Profit of 68 on sale
2025-02-18	BUY	70	57.280	58.770	58.621	USD 4,103	54.19
2025-02-13	BUY	14	56.810	57.260	57.215	USD 801	54.02
2025-02-12	BUY	14	56.020	56.720	56.650	USD 793	53.98
2025-02-11	BUY	42	57.510	58.470	58.374	USD 2,452	53.91
2025-02-06	BUY	126	59.700	62.150	61.905	USD 7,800	53.58
2025-01-27	BUY	14	59.720	59.840	59.828	USD 838	52.27
2024-12-30	BUY	70	55.300	56.970	56.803	USD 3,976	51.78
2024-12-06	BUY	56	56.370	57.180	57.099	USD 3,198	51.28
2024-12-05	BUY	14	56.520	58.560	58.356	USD 817	51.10
2024-12-04	BUY	70	58.150	59.850	59.680	USD 4,178	50.85
2024-11-29	BUY	70	58.140	58.500	58.464	USD 4,092	49.95
2024-11-27	BUY	56	57.760	59.830	59.623	USD 3,339	49.27
2024-11-26	BUY	14	58.750	58.810	58.804	USD 823	48.84
2024-11-21	BUY	70	56.710	58.490	58.312	USD 4,082	47.37
2024-11-20	BUY	42	57.260	57.340	57.332	USD 2,408	46.82
2024-11-18	BUY	168	52.890	53.780	53.691	USD 9,020	45.88
2024-11-12	BUY	112	55.890	57.810	57.618	USD 6,453	45.21
2024-11-08	BUY	70	54.000	54.470	54.423	USD 3,810	44.58
2024-11-07	BUY	210	50.030	50.760	50.687	USD 10,644	44.16
2024-11-06	BUY	28	48.040	48.770	48.697	USD 1,364	43.84
2024-10-31	BUY	14	44.040	45.610	45.453	USD 636	43.62

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VCEL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	224,250	38	329,502	68.1%
2025-09-18	210,642	4,505	422,656	49.8%
2025-09-17	498,057	18	848,500	58.7%
2025-09-16	247,690	103	604,158	41.0%
2025-09-15	250,454	2,198	479,717	52.2%
2025-09-12	226,773	0	440,921	51.4%
2025-09-11	434,580	0	1,188,986	36.6%
2025-09-10	217,511	4	507,036	42.9%
2025-09-09	154,922	1,002	432,147	35.8%
2025-09-08	119,006	0	262,990	45.3%
2025-09-05	205,601	0	280,269	73.4%
2025-09-04	194,429	0	640,877	30.3%
2025-09-03	164,172	465	276,644	59.3%
2025-09-02	115,485	0	201,163	57.4%
2025-08-29	79,439	0	137,361	57.8%
2025-08-28	73,132	0	128,831	56.8%
2025-08-27	224,056	330	450,386	49.7%
2025-08-26	220,373	0	479,253	46.0%
2025-08-25	109,655	0	154,175	71.1%
2025-08-22	231,253	0	366,466	63.1%
2025-08-21	270,342	34,260	440,518	61.4%
2025-08-20	61,162	800	88,729	68.9%
2025-08-19	55,652	350	83,440	66.7%
2025-08-18	223,281	0	397,650	56.2%
2025-08-15	152,782	0	279,452	54.7%
2025-08-14	121,231	43	191,225	63.4%
2025-08-13	155,539	0	317,598	49.0%
2025-08-12	99,112	6,742	139,272	71.2%
2025-08-11	127,401	0	226,595	56.2%
2025-08-08	108,400	0	153,589	70.6%
2025-08-07	158,721	777	213,186	74.5%
2025-08-06	144,941	169	222,689	65.1%
2025-08-05	113,364	0	155,460	72.9%
2025-08-04	202,114	0	265,406	76.2%
2025-08-01	209,380	4,620	311,185	67.3%
2025-07-31	458,933	6,157	947,634	48.4%
2025-07-30	201,101	400	266,955	75.3%
2025-07-29	156,116	34	217,866	71.7%
2025-07-28	126,810	33	181,312	69.9%
2025-07-25	66,015	0	116,396	56.7%
2025-07-24	98,110	197	186,190	52.7%
2025-07-23	190,556	0	299,773	63.6%
2025-07-22	94,561	2,782	216,240	43.7%
2025-07-21	98,734	0	243,030	40.6%
2025-07-18	90,833	60	240,256	37.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE